Event

Christopher van Deusen

PhD
Omdana Therapeutics

Peiran Yang

Ph.D
Brigham and Women's Hospital / Harvard Medical School

Marc Ferrer

PhD
National Center for Advancing Translational Sciences, National Institutes of Health

Juan J. Marugan

PhD
National Center for Advancing Translational Sciences, National Institutes of Health

Kenneth J. Wilson

PhD
National Center for Advancing Translational Sciences, National Institutes of Health

Lai-Ming Yung

Ph.D
Brigham and Women's Hospital / Harvard Medical School

Mark Southwood

PhD
Papworth Hosp;Papworth Hospital

Shannon C. Dwyer

PhD
Sanofi

Alexander I. Agoulnik

PhD
Florida International University

Zhiqiang Jia

M.D.
Sanofi

Noel Southall

PhD
National Center for Advancing Translational Sciences, National Institutes of Health

Stephane Illiano

PhD
Sanofi

Geoffrey Bocobo

B.S.
Brigham and Women's Hospital / Harvard Medical School

Jean Cavallo

PhD
Sanofi

Paul B. Yu

MD, PhD
Brigham and Women's Hospital / Harvard Medical School

Nicholas W. Morrell

MD
Addenbrookes Hosp;Addenbrookes Hospital;University of Cambridge

David Chain

M.S.
Sanofi

Teresa Dinter

B.S.
Brigham and Women's Hospital / Harvard Medical School

ML290, an Allosteric Relaxin-RXFP1 Agonist, Attenuates Experimental Pulmonary Hypertension